UK health regulator approves GSK’s vaccine for common respiratory virus RSV, Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com

The Medicines and Healthcare products Regulatory Agency (MHRA) authorised GSK’s shot, called Arexvy, for active immunisation to prevent lower respiratory tract disease caused by RSV in adults 60 years and older., The Medicines and Healthcare products Regulatory Agency (MHRA) authorised GSK’s shot, called Arexvy, for active immunisation to prevent lower respiratory tract disease caused by RSV in adults 60 years and older., , Read More